Which Tarbell fans are making a difference right now?
Pioneering journalism that informs, galvanizes and changes America.
Tarbell uncovers how powerful people and companies use their influence to shape a system that works for them, not you. We highlight solutions to pressing problems. Our fiercely independent, unbiased news inspires our members in all 50 U.S. states to take action.
Tarbell is reader-funded. We are nonprofit. We do not accept advertising, money from corporations or from corporate foundations.
Have a question or tip for a story? Email questions@tarbell.org. Want to work with us? Email hello@tarbell.org.
Should the number of operations that a surgeon performs be their main criteria for judgment? Certainly not, but that number offers patients some crucial, basic information about their surgeon.
The Darkest Money In Washington: Business Groups Spend More On Advocacy And Consulting Than Lobbying
Is the beloved program on its last legs?
Hahnemann University Hospital in Philadelphia is slated to close in September, less than two years after a private equity firm bought it.
Under The Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
Under The Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
Sen. Harris’ plan won’t work and history will prove it. I know because I’ve been there.
Under The Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
Where will private insurance fit into a Medicare for All system – and would it be worth saving either way? A health policy professor emeritus explores.
Under The Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
Facebook has faced myriad legal settlements time and again, so a $5 billion fine from the FTC will not make them sweat.
Price-cutting initiatives have been pulled off the White House docket, and drug makers are working hard to maintain their rising profits.
The Democratic congresswoman and former HHS secretary called a bill to allow her state to import cheaper drugs from Canada “the silliest thing I’ve ever heard of.”
A Tennessee physician and professor watches his state shred the medical safety net of his state.
Under The Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
Amgen and Astellas were fined more than $125 million combined for skirting Medicare payment requirements to help lower-income consumers. But a fine that small does not send much of a message.
The Ballad Health merger has been raising alarms among physicians serving the coverage area since its announcement.
A former Eli Lilly & Co finance department employee gives an insider’s look at how the company started ratcheting up prices for critical drugs.
One of the hidden costs of long-term care is caregiving, and it’s increasingly vexing the individuals who take responsibility for their elderly relatives and others with continuing illnesses.
If a lobbyist group can shell out five-figures speaker fees, an organization will find a range of Washington journalists, pundits and former politicians prepared to appear at their issue-focused events.
Under the Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.
Axelrod said that Medicare for All has “become a phrase as much as anything else.”
Under the Influence is Tarbell’s weekly roundup of stories and ideas related to how special interests operate in America.